Technology · Software - Application · Synthos Deep Dive · 2026-07-03
| Verdict | Hold — systematic Synthos tier |
| Price (2026-07-02) | $373.14 · market cap ~$103B |
| Synthos scores (0–10) | Downside Risk 7 · Growth Quality 8 · Exponential Potential 5 |
| Synthos fair value (base case) | ~$400 → +7% · full range $270 (bear) – $500 (bull) |
| Street consensus | $413 (high $440 / low $370; 26 Buy · 4 Hold · 1 Sell) — context, not our anchor |
| Valuation | 87× trailing GAAP EPS · 47× FY26E · 40× FY27E · 34× FY28E (non-GAAP) · EV/S 18.9× · EV/EBITDA 53× |
| Exponential Potential | 5/10 · Moderate — ~10% forward revenue CAGR, real agentic-AI optionality, but growth decelerating and law-of-large-numbers at $103B caps the multibagger |
| Technicals | Uptrend — $373, −10% off 52-wk high, above 50/200-DMA, RSI 42 (neutral), +20.6% 12-mo = SPY, lagging QQQ (+30%) |
| Conviction | Moderate — 3 independent net-bullish voices, 7 reconciled claims (top skill 1.0: Business Breakdowns, Jensen Huang) |
| Position sizing | Quality-watchlist; 0% now, size 2–4% on a pullback into the low-$300s / a multiple reset |
| Next catalyst | 2026-07-27 Q2'26 earnings (Street EPS $2.05 non-GAAP) |
| Single biggest risk | Multiple compression — 47× forward on ~10% revenue growth leaves no margin for a single soft quarter or China/export shock |
One-line thesis. Cadence is one half of a genuinely mission-critical EDA duopoly with a fortress balance sheet (net cash), 89% gross margins and a record $8.0B backlog — a wonderful business whose stock already prices in years of flawless execution, so the honest call is Watch and wait for a better entry, not chase 47× forward earnings on a decelerating ~10% top line.
Cadence makes the software that engineers use to design computer chips. You physically cannot design a modern chip — the ones inside your phone, your car, or an AI data center — without tools from Cadence or its one real rival, Synopsys. That gives it enormous, durable pricing power: two companies split a market everyone needs.
The business is excellent: it keeps about 89 cents of gross profit on every sales dollar, carries more cash than debt, and has a record pile of signed-but-not-yet-delivered orders ($8 billion). The catch: the stock is very expensive. You're paying roughly 47 times next year's expected profit for a company whose sales are growing around 10–17% a year — a great company at a demanding price. Our verdict is Watch: keep it on the list, but wait for the price to come down or the growth to speed up before buying.
Here's what our three scores mean in everyday terms:
The one big worry: at this price, the stock needs everything to go right. Any stumble — a soft quarter, tighter China/export rules, or growth slowing further — could knock it down 20%+ even if the business stays healthy.
Solid = price · dashed = 50-day average · dotted = 200-day average · amber = 52-week high/low. Price above both averages is an uptrend.
The shaded band widens when the stock gets more volatile. Riding the upper edge = strong momentum (sometimes stretched); the lower edge = weak / potentially oversold.
Above 70 (red band) = overbought, below 30 (green band) = oversold. Currently 48.
Blue crossing above amber (bars flip green) = momentum turning up; below (bars red) = turning down. Bar height = the size of that gap.
Solid = CDNS · dashed = S&P 500 · dotted = XLK (sector). A rising line means it is beating that benchmark — the sector line shows whether it is a leader or laggard within its own group.
Darker bars = actual results, brighter = analyst estimates. Taller bars to the right = expected growth.
“Cadence and Synopsys are a mission-critical EDA duopoly; you literally cannot design a chip without their tools, giving durable pricing power.”
“Software-licensing firms like Cadence, Synopsys, Siemens will grow much larger as they add specialized token rental to their business models.”
“NVIDIA's go-to-market embeds AI libraries into IT ecosystem partners—ServiceNow, SAP, Siemens, Cadence, Synopsys—to build agentic AI.”
Every claim reconciles to a real claim_id in the Synthos knowledge base — this is the evidence the verdict is built on, not vibes. Management (the company itself) is shown but half-weighted; one cautionary voice is included on purpose.
Cadence Design Systems (Nasdaq: CDNS), founded 1987 and headquartered in San Jose, is a leader in electronic design automation (EDA) — the software, IP, and specialized hardware used to design and verify semiconductors and electronic systems. Its portfolio spans functional verification (Xcelium, JasperGold, and the Palladium/Protium emulation and prototyping hardware), digital IC design and signoff (Genus, Innovus, Joules), custom/analog design (Virtuoso, Spectre), system design and analysis (PCB and multiphysics), and a growing IP business (HBM, LPDDR, PCIe, SerDes). The newest strategic thrust is agentic AI — the AgentStack orchestration layer with ChipStack, ViraStack, and InnoStack "Super Agents." Fiscal year ends December 31. CEO: Anirudh Devgan.
Revenue mix (FY2025, from filings):
Coverage in the Synthos KB is thin but directionally supportive: 7 traceable claims, 3 net-bullish voices, net conviction ~+78 (entity-only, skill- and recency-weighted). This is not a high-breadth conviction name — the verdict is primarily fundamentals- and quant-driven, with the KB as corroboration rather than the anchor. Two threads:
business_breakdowns-qZ0t_p4Wktw:06e999f785, bullish, conviction 90, skill 1.0): "Cadence and Synopsys are a mission-critical EDA duopoly; you literally cannot design a chip without their tools, giving durable pricing power." This is the load-bearing structural claim and it squares with the 89% gross margin and record backlog.jensen_huang-xv7UVAfyebk:5537104b3a, bullish, conviction 80, skill 1.0): software-licensing firms like Cadence, Synopsys and Siemens "will grow much larger as they add specialized token rental to their business models." Huang again (jensen_huang_ai-k82RwXqZHY8:66da40e4dd, conviction 65): NVIDIA embeds AI libraries into ecosystem partners including Cadence to build agentic AI. Honest weighting: Huang is talking his own book — Cadence is an NVIDIA ecosystem partner and customer, so treat this thread as optionality, not core proof.Honest composite note. The panel is small and skewed toward one structural insight plus NVIDIA-adjacent enthusiasm. There is no deep, independent, multi-voice financial-analyst chorus here the way there is for a mega-cap flagship. That thinness is exactly why the verdict rests on the numbers, and why the numbers — at 47× forward — argue for patience.
The one-glance judgment — three scores, 0–10, each anchored to real metrics (not probabilities we can't honestly calibrate):
| Score | 0–10 | The read |
|---|---|---|
| Downside Risk (lower = safer) | 7 · Elevated | Business is sturdy (net cash, 89% GM, beta 1.15), but valuation is the risk: 87× trailing GAAP / 47× forward non-GAAP on ~10% revenue growth. FMP letter rating B-, P/E score 1/5. China/export exposure adds a structural flag. |
| Growth Quality | 8 · Very High | ~10% forward revenue CAGR (17% guided FY26), 89% gross margin, 21% ROE, 12% ROIC, and a duopoly moat — elite quality, just not hyper-growth. |
| Exponential Potential | 5 · Moderate | Real agentic-AI and IP optionality, but the estimate curve decelerates (EPS $10.94 FY28E → $11.15 FY30E, nearly flat) and a $103B cap limits the multibagger. A small accelerating name with this moat would score 8. |
The three cases (our own scenario model — assumptions shown; each target is a ~12–18-month fair value). We deliberately do not attach probabilities: the base case is the expected path, so a weighted blend would just restate it with false precision. The cases bound the range; the scores summarize them. (EPS figures are non-GAAP, the basis on which the Street models CDNS and management guides.)
| Case | Key assumptions | Fair value |
|---|---|---|
| Bull | AI/agentic + IP demand reaccelerates; backlog converts ahead of plan. FY27E EPS beats to ~$10.0 (vs $9.37 cons); the market keeps paying a premium ~50×. | ~$500 (+34%) |
| Base (our anchor) | Estimates roughly hit — FY27E non-GAAP EPS $9.37; a durable ~10–15% compounder with 89% GM and a duopoly moat holds a ~43× multiple. | ~$400 (+7%) |
| Bear | China/export headwinds bite, hardware lumpiness or a growth-scare quarter; the multiple de-rates toward the software average. FY27E EPS ~$8.5; multiple compresses to ~32×. | ~$270 (−28%) |
Synthos fair value = the base case, ~$400 (+7%), with the full $270–$500 span as the honest range. Our base sits just below the Street's $413 consensus — we take the deceleration and the demanding multiple more seriously than the sell side. Note the Street's low target ($370) is essentially today's price, telling you even bulls see limited near-term cushion. This is a tracked call — the Forecaster Scorecard grades it once it matures.
Synthos separates compounders (durable high returns on capital) from exponentials (accelerating multi-baggers-from-here). CDNS is a high-quality compounder, not an exponential:
Exponential Potential: Moderate (5/10). Own it — eventually — for durable ~10–15% earnings compounding plus real agentic-AI optionality, not for a fast multibagger. The score is honest, not a default 5: it reflects a great moat (pushes up) offset by clear deceleration and a large cap (pull down).
There is no way to call CDNS cheap. Trailing 87× GAAP EPS, 18.9× sales, 53× EV/EBITDA; FMP's letter rating is B- with a 1/5 P/E score and 1/5 P/B score. The bull's defense is that non-GAAP EPS compounds and the forward multiple compresses: 47× FY26E → 40× FY27E → 34× FY28E (non-GAAP). But note the multiple stops compressing after FY28 because earnings growth itself flattens — FY28E $10.94 → FY30E $11.15. A reverse read: today's ~$373 requires the market to keep paying a low-to-mid-40s multiple on a business decelerating toward ~10% growth — i.e. CDNS is priced for continued premium sentiment, with essentially no margin for a soft quarter. Street targets (context): consensus $413, high $440, low $370 — the low target equals today's price, and our $400 base FV sits just under consensus. Not a value buy; a wonderful-business-at-a-full-price where patience is the edge.
Cadence's moat is among the widest in software: (1) a structural duopoly with Synopsys — you cannot tape out a modern chip without one of them, and switching costs are prohibitive because design flows, IP, and engineer training are deeply embedded (business_breakdowns-qZ0t_p4Wktw:06e999f785); (2) mission-critical positioning — EDA is a small slice of a chipmaker's budget but gates billions in silicon, so customers are price-insensitive; (3) a compounding IP library (HBM, PCIe, SerDes) and now agentic-AI tooling that deepens lock-in. The 89% gross margin and record $8.0B backlog are the moat made visible.
Peer set (FMP-supplied, market cap): the only true comparable is Synopsys (SNPS) $84B — the other half of the duopoly. The rest of FMP's list is loosely related large-cap tech rather than direct competitors: Autodesk $44B, Dell $262B, Corning $169B, Motorola Solutions $70B, Strategy $30B, NetEase $81B, Roblox $40B, Snowflake $90B, Workday $35B. Against SNPS, CDNS trades at a similar premium; the pair moves together and both benefit from the same AI-design tailwind.
jensen_huang-xv7UVAfyebk:5537104b3a) becoming real revenue is the biggest upside swing.Thesis tripwires (what would change the call): two consecutive quarters of decelerating backlog or bookings; a China/export revenue shock; non-GAAP operating margin slipping below ~42%; or a multiple expansion toward 55×+ without an earnings-growth reacceleration (which would push us from Watch toward Avoid on valuation).
Watch. Cadence is a genuinely elite business — a mission-critical EDA duopoly with a net-cash balance sheet, 89% gross margins, 30% FCF margins, a record $8.0B backlog, and a raised 17% FY26 growth guide. If the only question were "is this a great company?", the answer is an emphatic yes. But the Synthos job is to judge the stock, and at 47× forward non-GAAP earnings on a ~10% (decelerating) revenue CAGR, the price already embeds years of flawless execution. Our base-case fair value (~$400) is only +7% and sits below Street consensus; the Street's own low target equals today's price. That asymmetry — modest upside, real de-rating downside — is a Watch, not a Buy.
claim_ids (cited inline). Fabricated conviction is structurally impossible (claim-ID reconciliation). This is a thin-coverage name; the verdict is fundamentals-/quant-driven with the KB as corroboration.